Skip to main content
European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Zawartość zarchiwizowana w dniu 2024-05-24

Heparanase inhibitors in antiangiogenic and antimetastatic cancer therapy

Cel

Inhibition of heparanase overexpressed by tumours, preventing not only the release and activation of angiogenic growth factors stored by heparan sulfate (HS) proteoglycans but also the disruption of the basement membrane and the extracellular matrix is regarded as a very promising strategy to develop anticancer drugs. This project aims at:
a) mapping the binding sites of heparanase for HS;
b) determining the structural requirements of HS-like polysaccharides for interaction with the enzyme as substrates and as inhibitors;
c) improving the heparanase-inhibiting properties of polysaccharides by generating specific sulfation patterns optimised on biological activity (inhibition of heparanase, antimetastatic-antiangiogenic activity).

These aims will be pursued through a study of the inhibition of heparanase with natural and synthetic HS-like oligo/polysaccharides, glycomimetics, and its in vivo effects.

Zaproszenie do składania wniosków

Data not available

System finansowania

CSC - Cost-sharing contracts

Koordynator

ISTITUTO SCIENTIFICO DI CHIMICA E BIOCHIMICA "G.RONZONI"
Wkład UE
Brak danych
Adres
Via Giuseppe Colombo 81
20133 MILANO
Włochy

Zobacz na mapie

Koszt całkowity
Brak danych

Uczestnicy (6)